An et al. showed that CD4+/CD25+/FOXP3+ regulatory T-cells were significantly increased in patients with extensive stage small cell lung carcinoma when compared to controls, while an enhanced proliferation potential of CD8+ T-cells was indicative of better progression-free survival [28]. The gene discussed is FOXP3; the disease is small cell lung carcinoma.